XML 44 R31.htm IDEA: XBRL DOCUMENT v3.20.4
Quarterly Financial Information (Unaudited)
 12 Months Ended
Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Information (Unaudited)

23.

Quarterly Financial Information (Unaudited)

 

(in millions, except per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2020 Quarter Ended

 

 

2019 Quarter Ended

 

 

 

Mar

 

 

Jun

 

 

Sep

 

 

Dec

 

 

Mar

 

 

Jun

 

 

Sep

 

 

Dec

 

Net sales

 

$

1,783.8

 

 

$

1,226.1

 

 

$

1,929.3

 

 

$

2,085.3

 

 

$

1,975.5

 

 

$

1,988.6

 

 

$

1,892.4

 

 

$

2,125.7

 

Gross profit

 

 

1,149.1

 

 

 

653.9

 

 

 

1,210.2

 

 

 

1,285.4

 

 

 

1,278.7

 

 

 

1,260.4

 

 

 

1,210.1

 

 

 

1,396.1

 

Net (loss) earnings of Zimmer

   Biomet Holdings, Inc.

 

 

(508.5

)

 

 

(206.6

)

 

 

242.5

 

 

 

333.7

 

 

 

246.1

 

 

 

133.7

 

 

 

431.1

 

 

 

320.7

 

(Loss) earnings per common

   share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

(2.46

)

 

 

(1.00

)

 

 

1.17

 

 

 

1.61

 

 

 

1.20

 

 

 

0.65

 

 

 

2.10

 

 

 

1.56

 

Diluted

 

 

(2.46

)

 

 

(1.00

)

 

 

1.16

 

 

 

1.59

 

 

 

1.20

 

 

 

0.65

 

 

 

2.08

 

 

 

1.54

 

 

In the three-month period ended March 31, 2020, we recorded goodwill impairment charges of $612.0 million.

 

Net sales in the three-month period ended December 31, 2020 include the benefit of expanded strategic sales, favorable bulk orders and shipment timing.

The TRAF has had a significant impact on our net (loss) earnings in certain quarters.  See Note 17 for further discussion on the quarterly impacts of TRAF.